Improved synthesis and quality control of [18F]PSMA-1007

被引：0
|
作者：
Fasel, Antje [1 ]
Martin, Rena [1 ]
Baumgart, Diana [1 ]
Weidlich, Sebastian [1 ]
Mueller, Marco [1 ]
机构：
[1] ABX Adv Biochem Cpds, Radeberg, Germany
来源：
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS | 2019年 / 62卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
P-072
引用
收藏
页码：S226 / S227
页数：2
相关论文
共 50 条
  • [41] Head-to-Head Comparison of [18F]PSMA-1007 and [18F]FDG PET/CT in Patients with Triple-Negative Breast Cancer
    Andryszak, Natalia
    Swiniuch, Daria
    Wojcik, Elzbieta
    Ramlau, Rodryg
    Ruchala, Marek
    Czepczynski, Rafal
    CANCERS, 2024, 16 (03)
  • [42] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Chikatamarla, Venkata Avinash
    Okano, Satomi
    Jenvey, Peter
    Ansaldo, Alexander
    Roberts, Matthew J.
    Ramsay, Stuart C.
    Thomas, Paul A.
    Pattison, David A.
    EJNMMI RESEARCH, 2021, 11 (01)
  • [43] [18F]PSMA-1007 PET/CT findings in patient with the third oligometastatic brain recurrence of prostate cancer
    Khalimon, A.
    Antonevskaya, T.
    Atakishieva, L.
    Khodzhibekova, M.
    Leontyev, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S866 - S866
  • [44] Head-to-Head Comparison of [18F]PSMA-1007 and [18F] FDG PET/CT in Patients with Triple-Negative Breast Cancer
    Andryszak, N.
    Swiniuch, D.
    Wojcik, E.
    Ramlau, R.
    Ruchala, M.
    Czepczynski, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S18 - S19
  • [45] Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
    Venkata Avinash Chikatamarla
    Satomi Okano
    Peter Jenvey
    Alexander Ansaldo
    Matthew J. Roberts
    Stuart C. Ramsay
    Paul A. Thomas
    David A. Pattison
    EJNMMI Research, 11
  • [46] Automated [18F]PSMA-1007 production by a single use cassette-type synthesizer for clinical examination
    Sadahiro Naka
    Tadashi Watabe
    Kenta Kurimoto
    Motohide Uemura
    Fumihiko Soeda
    Oliver C. Neels
    Klaus Kopka
    Mitsuaki Tatsumi
    Hiroki Kato
    Norio Nonomura
    Eku Shimosegawa
    Jens Cardinale
    Frederik L. Giesel
    Jun Hatazawa
    EJNMMI Radiopharmacy and Chemistry, 5
  • [47] CLINICAL INSIGNIFICANCE OF [18F]PSMA-1007 AVID NON-SPECIFIC BONE LESIONS: A RETROSPECTIVE EVALUATION
    Arnfield, E.
    Thomas, P.
    Roberts, M.
    Pelecanos, A.
    Ramsay, S.
    Lin, C.
    Latter, M.
    Garcia, P.
    Pattison, D.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 11 - 11
  • [48] CLINICAL AND BIOCHEMICAL PREDICTORS OF [18F]PSMA-1007 PET IMAGING OF PROSTATE CANCER AT STAGING AND BIOCHEMICAL RECURRENCE
    Chikatamarla, A.
    Okano, S.
    Ansaldo, A.
    Jenvey, P.
    Thomas, P.
    Ramsay, S.
    Roberts, M.
    Pattison, D.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 12 - 12
  • [49] The prognostic role of staging [18F]PSMA-1007 PET/CT volumetric and dissemination features in prostate cancer
    Albano, Domenico
    Temponi, Alessandro
    Bertagna, Francesco
    Suardi, Nazareno
    Talin, Anna
    Bonu, Marco Lorenzo
    Triggiani, Luca
    ANNALS OF NUCLEAR MEDICINE, 2025, : 518 - 526
  • [50] Role of [18F]-PSMA-1007 PET radiomics for seminal vesicle invasion prediction in primary prostate cancer
    Luo, Liang
    Wang, Xinyi
    Xie, Hongjun
    Liang, Hua
    Gao, Jungang
    Li, Yang
    Xia, Yuwei
    Zhao, Mengmeng
    Shi, Feng
    Shen, Cong
    Duan, Xiaoyi
    Computers in Biology and Medicine, 2024, 183
12345